BSECentenial Surgical Suture Ltd· Healthcare Equipment & SuppliesHighNegative
Announced Tue, 17 Feb, 2026 · 01:31 IST

PFA

Sebi InvestigationRegulatory & Legal View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.0%Reaction day
₹98.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+1.0% vs market
Medical Equipment & Supplies peers, median of 12sector+1.1%+0.9% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.9 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.0+1.0+1.0+1.1+0.9
Next day
+2.0+1.3+0.8+1.8+0.2
2d
—-0.2—+1.0—
3d
-3.3-0.3-3.0+2.5-5.8
4d
—-0.2—+1.7—
5d
-10.2-1.4-8.8-1.0-9.2
1w
-13.7-1.0-12.7-1.7-12.0
15d
-4.3-6.3+2.0-3.1-1.2
1m
-8.9-9.0+0.1-5.7-3.2
2m
+2.3+3.5-1.2+7.1-4.7
3m
-4.1+4.6-8.7-6.1+2.1
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Centenial Surgical Suture Ltd (Scrip: 531308) has written to BSE's Investigation/Surveillance Department flagging abnormal price rise in its shares between February 6-13, 2026, which was not supported by any corporate announcements or business changes. The company observed suspicious trades in tiny lots (1 to 50 shares) involving multiple individuals, with the top five buyers and sellers contributing over 90% to the positive last traded price (LTP) variance. The company alleges circular trading and collusion among connected entities to artificially inflate the share price. It has formally requested SEBI to investigate under the PFUTP Regulations and take penal action against the involved brokers and clients. The company clarified that its promoters, directors, and key managerial personnel have not traded in the stock during this period.

Likely market impact

This filing signals heightened regulatory risk for the stock — a formal SEBI investigation could lead to volatility, potential trading restrictions, or corrective action. Shareholders should expect possible sharp price swings and should treat the stock as high-risk until the probe concludes.